To assess the short-term and long-term efficacy and safety of cladribine in people with any form of multiple sclerosis.
This is a protocol.
Cladribine for people with multiple sclerosis
You may also be interested in:
- Teriflunomide modifies the disease course in people with multiple sclerosis
- The effect of the immunosuppressive drug cyclophosphamide in people with multiple sclerosis
- The use of methotrexate, an immunomodulator drug, for treating people with multiple sclerosis
- The use of the immunosuppressive drug mitoxantrone (MX) in people with multiple sclerosis (MS)
- The effects of the immunosuppressive drug azathioprine (AZA) widely used in multiple sclerosis (MS) before the treatments with interferons or glatiramer acetate
Health topics: